Literature DB >> 31729741

Predictive factor of recurrence after curative resection for stage I-II colon cancer.

Wejih Dougaz, Ibtissem Bouasker, Esma Leila Gouta, Mehdi Khalfallah, Annouar Oueslati, Imene Samaali, Wafa Ghariani, Hichem Jerraya, Ramzi Nouira, Chadli Dziri.   

Abstract

BACKGROUND: Colon cancer has become a common malignant neoplasm in Tunisia. Patients with negative lymph node have a 5 years recurrence rate of 21.1%. Studies reporting the prognostic factors of recurrence for patients with stage I-II colon cancer are limited. AIM: This study aimed to determine factors predicting recurrence for patients with stage I-II colon cancer after curative resection.
METHODS: This was a retrospective cohort study. Were included patients who underwent curative surgery for stage I or II colon cancer. Enrolled variables were subdivided into: Pre-operative, Intraoperative and Post-operative variables. Main outcome measures were local recurrence and distant metastasis detected during follow-up.
RESULTS: Eighteen men and 17 women with median age of 61 years, ranging from 33 to 89, were enrolled in this study. Twenty-eight patients out of 35 were classified T3 and T4 colon cancer. The mean number of lymph nodes harvested was 16.23 (median= 17; range: 4-44). Ten patients (28%) had colloid component in the tumor. At a median follow-up of 23 months (range: 6-56 months), recurrence was observed in five cases (14%). Variables associated to recurrence were Carcinoembryonic antigen level (p= 0.03), serum albumin level (p=0.029) and the presence of colloid component (0.02). Multivariate logistic regression retained colloid component as the only predictive factor of recurrence (OR=1.2, 95%CI [1.019-1.412], p=0.028).
CONCLUSIONS: This study showed that the percentage of mucinous component equal or greater than 25% was the only predictive factor of recurrence for curatively resected, stages I and II, colon cancer.

Entities:  

Mesh:

Year:  2019        PMID: 31729741

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  2 in total

1.  The Value of Serum miR-139-3p Expression Level in Predicting Postoperative Survival of Colon Cancer Patients.

Authors:  Guohong Fu; Haimei Xu; Cong Zhou
Journal:  Int J Gen Med       Date:  2022-02-11

2.  A retrospective study based on SEER database: not all high-risk factors are equal for stage II colon cancer.

Authors:  Dong Li; Zongze Jiang; Lili Xiang; Chuanhua Yang; Feiwu Long; Wenneng Liu
Journal:  Transl Cancer Res       Date:  2022-04       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.